Group One Trading
MIRM icon

Group One Trading’s Mirum Pharmaceuticals MIRM Stock Holding History

Group One Trading’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-872
Closed -$68.9K – 8301
2025
Q4 		$68.9K Buy
872
+640
+276% +$45.9K ﹤0.01% 5319
2025
Q3 		$17K Buy
232
+186
+404% +$11.8K ﹤0.01% 6821
2025
Q2 		$2.34K Buy
+46
New +$2.05K ﹤0.01% 7370
2023
Q4 		– Sell
-1,527
Closed -$46.2K – 7865
2023
Q3 		$48.3K Buy
1,527
+880
+136% +$24.1K ﹤0.01% 5128
2023
Q2 		$16.7K Buy
647
+347
+116% +$9.23K ﹤0.01% 6100
2023
Q1 		$7.21K Buy
+300
New +$6.84K ﹤0.01% 6122
2022
Q3 		– Sell
-500
Closed -$10K – 7949
2022
Q2 		$10K Sell
500
-1,500
-75% -$35.4K ﹤0.01% 6757
2022
Q1 		$44K Hold
2,000
– – ﹤0.01% 6187
2021
Q4 		$32K Sell
2,000
-3,000
-60% -$46.7K ﹤0.01% 6676
2021
Q3 		$100K Buy
+5,000
New +$81.3K ﹤0.01% 5911

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Group One Trading's MIRM Position: Q1 2026 in Review

Group One Trading sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 872 shares — an estimated $68.9K sold.

Group One Trading first reported a position in MIRM in Q3 2021 and held it in 10 quarters. The position peaked at $100K in Q3 2021. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Group One Trading reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 872 Mirum Pharmaceuticals shares in Q1 2026, an estimated $68.9K.
  • Group One Trading first reported a position in Mirum Pharmaceuticals in Q3 2021 and held it in 10 quarters.
  • Group One Trading's Mirum Pharmaceuticals position peaked at $100K in Q3 2021.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.